Mulmit

Vir Biotechnology, Inc.Vir Biotechnology, Inc.

VIR Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3168,556,000-479,328,000-437,987,000-3.16
2024-12-3174,205,000-587,165,000-521,960,000-3.83
2023-12-3186,180,000-684,305,000-615,117,000-4.59
2022-12-311,615,797,000833,068,000515,837,0003.83
2021-12-311,095,415,000420,751,000528,584,0003.96

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-11MORE ROBERT J8,000
2026-08-11MORE ROBERT J8,000
2026-06-09Coughlin Timothy8,000
2026-06-09Coughlin Timothy8,000
2026-06-09Coughlin Timothy16,000
2026-06-09Coughlin Timothy16,000
2026-06-01Napolitano Janet3,200
2026-06-01Sabatini BrentSVP, Chief Accounting Officer379
2026-05-27Sigal Charles Elliott8,000
2026-05-27Sigal Charles Elliott16,000
2026-05-27Napolitano Janet8,000
2026-05-27Napolitano Janet16,000

8-K events

FiledItems
2026-08-05Results of operations · Financial statements and exhibits
2026-07-24Officer or director change
2026-06-10Officer or director change
2026-05-28Officer or director change · Submission of matters to a vote
2026-05-06Results of operations · Financial statements and exhibits
2026-04-10Officer or director change
2026-03-04Officer or director change
2026-03-02Other events
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.

한국 시장 대시보드Korea dashboard 미국·글로벌 대시보드US & Global dashboard